• Company
• MSD Korea begins voluntary retirement
• by Jung, Sae-Im May 15, 2023 05:40am

• Company
• Advate leading hemophilia treatment
• by Nho, Byung Chul May 12, 2023 05:45am

• Company
• SK Biopharm’s cenobamate secures KRW 700 billion
• by Chon, Seung-Hyun May 12, 2023 05:45am

• Policy
• Youkyung Oh was appointed as the first chairman of APFRAS
• by Lee, Hye-Kyung May 12, 2023 05:44am

• Policy
• HIRA plans to report on the re-evaluation
• by Lee, Tak-Sun May 12, 2023 05:44am

• Company
• SU's strengths maximized through combined use with SGLT-2is
• by Kim, Jin-Gu May 12, 2023 05:44am

• Policy
• Triple-negative breast cancer tx Trodelbi approved in Korea
• by Lee, Hye-Kyung May 11, 2023 05:50am

• Policy
• ‘Pay more policy attention to advanced heart failures'
• by Hwang, byoung-woo May 11, 2023 05:49am

• Policy
• Rapidly changing breast cancer treatment
• by Choi, sun May 11, 2023 05:49am

• Company
• Scemblix can be prescribed at general hospitals
• by Eo, Yun-Ho May 11, 2023 05:48am